Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Dania Therapeutics ApS
APS
Active
Reklamebeskyttelse
CVR 42523925
Store Kongensgade 77, 1264
København K
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
1 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Dania Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
KA
Karl Agger
Founder
Founder
2021
Former (1)
HM
Hamed Mozaffari Brodersen
Management
Management
2021 – 2026
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (2)
MM
Michael Manchuan Li
Board of Directors
Board of Directors
2023
KA
Karin Absalonsen
Chairman
Chairman
2021
Former (2)
KA
Kim Andersen
Board of Directors
Board of Directors
2021 – 2024
LM
Lars Michael Wood
Board of Directors
Board of Directors
2021 – 2023
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Kristian Helin
Individual
33.33–49.99%
33.33–49.99%
2022
Vernalis (R&D) Limited
Individual
25–33.32%
25–33.32%
2022
Hannibal Innovation ApS
Company
15–19.99%
15–19.99%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Dania Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
